Tian-Hao Weng

1.8k total citations · 1 hit paper
25 papers, 1.1k citations indexed

About

Tian-Hao Weng is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Tian-Hao Weng has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Tian-Hao Weng's work include SARS-CoV-2 and COVID-19 Research (5 papers), Influenza Virus Research Studies (5 papers) and Viral Infections and Outbreaks Research (4 papers). Tian-Hao Weng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Influenza Virus Research Studies (5 papers) and Viral Infections and Outbreaks Research (4 papers). Tian-Hao Weng collaborates with scholars based in China, United States and Hong Kong. Tian-Hao Weng's co-authors include Hangping Yao, Zhigang Wu, Nanping Wu, Lanjuan Li, Xiangyun Lu, Linfang Cheng, Danrong Shi, Sai Li, Max Crispin and Jianlin Lei and has published in prestigious journals such as Cell, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Tian-Hao Weng

25 papers receiving 1.1k citations

Hit Papers

Molecular Architecture of the SARS-CoV-2 Virus 2020 2026 2022 2024 2020 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Molecular Architecture of the SARS-CoV-2 Virus
    2020 703 citations Hangping Yao, Yutong Song et al. Cell profile →

Peers

Tian-Hao Weng
Danrong Shi China
Zheyuan Zhang China
Naveenchandra Suryadevara United States
Amrita Ojha United States
Qiyu Sun China
Antoni G. Wrobel United Kingdom
Leo Hanke Sweden
Brian D. Quinlan United States
Zhiteng Li China
Danrong Shi China
Tian-Hao Weng
Citations per year, relative to Tian-Hao Weng Tian-Hao Weng (= 1×) peers Danrong Shi

Countries citing papers authored by Tian-Hao Weng

Since Specialization
Citations

This map shows the geographic impact of Tian-Hao Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian-Hao Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian-Hao Weng more than expected).

Fields of papers citing papers by Tian-Hao Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian-Hao Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian-Hao Weng. The network helps show where Tian-Hao Weng may publish in the future.

Co-authorship network of co-authors of Tian-Hao Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Tian-Hao Weng. A scholar is included among the top collaborators of Tian-Hao Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian-Hao Weng. Tian-Hao Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Qian, Jun Xu, Dandan Zhu, et al.. (2025). Ghrelin attenuates metabolic dysfunction-associated steatotic liver disease by activating glutamine metabolism via inhibition of the IRE1α-XBP-1 pathway. Biochemical Pharmacology. 240. 117089–117089. 1 indexed citations
2.
Wu, Xiaoxin, Tian-Hao Weng, Linfang Cheng, et al.. (2024). Host proteins interact with viral elements and affect the life cycle of highly pathogenic avian influenza A virus H7N9. Heliyon. 10(7). e28218–e28218. 3 indexed citations
3.
Shi, Danrong, Tian-Hao Weng, Jie Wu, et al.. (2021). Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study. Frontiers in Immunology. 12. 708184–708184. 24 indexed citations
4.
Weng, Tian-Hao, Yan Dong, Danrong Shi, et al.. (2021). The MSP‐RON pathway regulates liver fibrosis through transforming growth factor beta‐dependent epithelial–mesenchymal transition. Liver International. 41(8). 1956–1968. 6 indexed citations
5.
Yao, Hangping, Yutong Song, Yong Chen, et al.. (2020). Molecular Architecture of the SARS-CoV-2 Virus. Cell. 183(3). 730–738.e13. 703 indexed citations breakdown →
6.
Weng, Tian-Hao, Minya Yao, Chen-Yu Hu, et al.. (2020). RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer. Cancer Research and Treatment. 52(3). 973–986. 21 indexed citations
7.
Yao, Hangping, Xiangyun Lu, Qiong Chen, et al.. (2020). Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo. Cell Discovery. 6(1). 76–76. 73 indexed citations
8.
Yao, Hangping, Yutong Song, Yong Chen, et al.. (2020). Molecular Architecture of the SARS-CoV-2 Virus. SSRN Electronic Journal. 3 indexed citations
9.
10.
Yao, Hangping, Liang Feng, Linghui Chen, et al.. (2019). Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy. Journal for ImmunoTherapy of Cancer. 7(1). 75–75. 19 indexed citations
11.
Yao, Hangping, Tian-Hao Weng, Chen-Yu Hu, et al.. (2018). RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE. Molecular Cancer Therapeutics. 17(12). 2654–2664. 23 indexed citations
12.
Weng, Tian-Hao, Chen-Yu Hu, Zhigang Wu, et al.. (2018). Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements. Frontiers in Microbiology. 9. 2724–2724. 3 indexed citations
13.
Weng, Tian-Hao, Ling Shen, Xiaoxin Wu, et al.. (2018). Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40. Cellular Physiology and Biochemistry. 50(3). 1055–1067. 4 indexed citations
14.
Wu, Xiaoxin, Xilong Deng, Wei Yao, et al.. (2018). The Protective Effects of the A/ZJU01/ PR8/2013 Split H7N9 Avian Influenza Vaccine Against Highly Pathogenic H7N9 in BALB/c Mice. Cellular Physiology and Biochemistry. 46(2). 633–643. 9 indexed citations
15.
Yao, Hangping, Liang Feng, Tian-Hao Weng, et al.. (2018). Preclinical Efficacy of Anti-RON Antibody–Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase. Molecular Pharmaceutics. 15(8). 3260–3271. 20 indexed citations
16.
Gao, Hainv, Yunfeng Xiao, Tian-Hao Weng, et al.. (2018). Bioinformatics Analysis on Potential Anti-Viral Targets Against Spike Protein of MERS-CoV. 55. 67–71. 2 indexed citations
17.
Qian, Yun, Limin Feng, Tian-Hao Weng, et al.. (2017). MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown. Cellular Physiology and Biochemistry. 44(2). 494–504. 18 indexed citations
18.
Wu, Xiaoxin, Yeping Wang, Tian-Hao Weng, et al.. (2017). Preparation of immunochromatographic strips for rapid detection of early secreted protein ESAT-6 and culture filtrate protein CFP-10 from Mycobacterium tuberculosis. Medicine. 96(51). e9350–e9350. 13 indexed citations
19.
Qian, Yun, Tian-Hao Weng, Frederick X.C. Wang, et al.. (2017). B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer. Human Pathology. 66. 79–85. 29 indexed citations
20.
Yao, Wei, Tian-Hao Weng, Frederick X.C. Wang, et al.. (2017). Longevity of protective immune responses induced by a split influenza A (H7N9) vaccine mixed with MF59 adjuvant in BALB/c mice. Oncotarget. 8(54). 91828–91840. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danrong Shi Breakdown of academic impact, for papers by Zheyuan Zhang Breakdown of academic impact, for papers by Naveenchandra Suryadevara Breakdown of academic impact, for papers by Amrita Ojha Breakdown of academic impact, for papers by Qiyu Sun Breakdown of academic impact, for papers by Antoni G. Wrobel Breakdown of academic impact, for papers by Leo Hanke Breakdown of academic impact, for papers by Brian D. Quinlan Breakdown of academic impact, for papers by Zhiteng Li
Rankless by CCL
2026